Your browser doesn't support javascript.
loading
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
Durham, Benjamin H; Lopez Rodrigo, Estibaliz; Picarsic, Jennifer; Abramson, David; Rotemberg, Veronica; De Munck, Steven; Pannecoucke, Erwin; Lu, Sydney X; Pastore, Alessandro; Yoshimi, Akihide; Mandelker, Diana; Ceyhan-Birsoy, Ozge; Ulaner, Gary A; Walsh, Michael; Yabe, Mariko; Petrova-Drus, Kseniya; Arcila, Maria E; Ladanyi, Marc; Solit, David B; Berger, Michael F; Hyman, David M; Lacouture, Mario E; Erickson, Caroline; Saganty, Ruth; Ki, Michelle; Dunkel, Ira J; Santa-María López, Vicente; Mora, Jaume; Haroche, Julien; Emile, Jean-Francois; Decaux, Olivier; Geissmann, Frederic; Savvides, Savvas N; Drilon, Alexander; Diamond, Eli L; Abdel-Wahab, Omar.
Afiliação
  • Durham BH; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lopez Rodrigo E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Picarsic J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Abramson D; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rotemberg V; UPMC Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • De Munck S; UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
  • Pannecoucke E; Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lu SX; Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Pastore A; Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
  • Yoshimi A; VIB-UGent Center for Inflammation Research, Ghent, Belgium.
  • Mandelker D; Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
  • Ceyhan-Birsoy O; VIB-UGent Center for Inflammation Research, Ghent, Belgium.
  • Ulaner GA; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Walsh M; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yabe M; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Petrova-Drus K; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Arcila ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ladanyi M; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Solit DB; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Berger MF; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hyman DM; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lacouture ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Erickson C; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Saganty R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ki M; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dunkel IJ; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Santa-María López V; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mora J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Haroche J; Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Emile JF; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Decaux O; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Geissmann F; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Savvides SN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Drilon A; Division of Pediatric Oncology, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
  • Diamond EL; Division of Pediatric Oncology, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
  • Abdel-Wahab O; Department of Internal Medicine, Assistance Publique-Hôpitaux de Paris, Centre de référence des histiocytosesUniversity Hospital La Pitié-Salpêtrière, Paris, France.
Nat Med ; 25(12): 1839-1842, 2019 12.
Article em En | MEDLINE | ID: mdl-31768065
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histiocitose / Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos / Proteínas Proto-Oncogênicas c-ret / Quinase do Linfoma Anaplásico Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Nat Med Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histiocitose / Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos / Proteínas Proto-Oncogênicas c-ret / Quinase do Linfoma Anaplásico Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Nat Med Ano de publicação: 2019 Tipo de documento: Article